| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
![[Search a list of Patent Appplications for class 424]](../as.gif) Class 424 | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
| Click here for a printable version of this file | |
![[List of Patents for class 424 subclass 1.11]](../ps.gif) | 1.11 | RADIONUCLIDE OR INTENDED RADIONUCLIDE CONTAINING; ADJUVANT OR CARRIER COMPOSITIONS; INTERMEDIATE OR PREPARATORY COMPOSITIONS |
| | 1.13 |  In aerosol, fine spray, effervescent, pressurized fluid, vapor or gas, or complete composition therefor |
| | 1.17 | Attached to or within viable or inviable whole micro-organism, cell, virus, fungus or specified sub-cellular structure thereof (e.g., platelet, red blood cell) |
| | 1.21 | Molecular bilayer structure (e.g., vesicle, liposome) |
| | 1.25 | Dissolving or eluting from solid or gel matrix (e.g., capsule, tablet) |
| | 1.29 | Coated, impregnated, or colloidal particulate (e.g., microcapsule, micro-sphere, micro-aggregate, macro-aggregate) |
| | 1.33 |  Delivery to active site involves particle dissolving, degrading, or otherwise releasing of radionuclide |
| | 1.37 | Radionuclide or intended radionuclide in an organic compound |
| | 1.49 | Attached to antibody or antibody fragment or immunoglobulin; derivative |
| | 1.53 | Attachment via an added element (e.g., bifunctional compound or coordinate, coupling agent, spacer compound, bridging compound, conjugated chelate) |
| | 1.57 | Attached to antigen or hapten; derivative thereof |
| | 1.61 | In an inorganic compound |
| | 1.65 | In an organic compound |
| | 1.69 | Attached to peptide or protein of 2+ amino acid units (e.g., dipeptide, folate, fibrinogen, transferrin, sp. enzymes); derivative thereof |
| | 1.73 | Attached to carbohydrate compound; derivative thereof (e.g., DNA, nucleotide, nucleoside, sugar, starch, tannin, saccharide, polysaccharide, cellulose, O-, N- and S-glycoside, vitamin B12) |
| | 1.77 | Phosphorus-containing organic compound |
| | 1.81 | Nonmetal radionuclide or intended radionuclide (e.g., carbon) |
| | 9.1 | IN VIVO DIAGNOSIS OR IN VIVO TESTING |
| | 9.2 | Testing efficacy or toxicity of a compound or composition (e.g., drug, vaccine, etc.) |
| | 9.3 | Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) |
| | 9.31 | Clay or zeolite containing |
| | 9.32 | Particle containing a transition, actinide, or lanthanide metal (e.g., hollow or solid particle, granule, etc.) |
| | 9.33 | Nitroxide or nitroxide containing |
| | 9.34 | Polypeptide attached to or complexed with the agent (e.g., protein, antibody, etc.) |
| | 9.35 | Carbohydrate or derivative thereof attached to or complexed with the agent |
| | 9.36 | Transition, actinide, or lanthanide metal containing |
| | 9.361 |  Heterocyclic compound is attached to or complexed with the metal |
| | 9.364 | Polyamino-polycarbonyl moiety attached to or complexed with the metal |
| | 9.37 | Imageable halogen containing |
| | 9.4 | X-ray contrast imaging agent (e.g., computed tomography, angiography, etc.) |
| | 9.41 | Barium containing |
| | 9.42 | Transition, actinide, or lanthanide metal containing |
| | 9.43 | Carbohydrate or derivative thereof attached to or complexed with the agent |
| | 9.44 | Hetero ring containing |
| | 9.45 | Halogenated benzene ring containing |
| | 9.451 | Two or more halogenated benzene rings in the same compound |
| | 9.452 |  Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| | 9.453 | Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| | 9.454 | Three or more amide groups are attached directly to the same benzene ring by nonionic bonding |
| | 9.455 | Carbonyl of a carboxylic acid or salt thereof attached directly to the benzene ring |
| | 9.5 | Ultrasound contrast agent |
| | 9.51 | Liposome containing |
| | 9.52 | Stable gas bubbles containing or intentional solubilized gas containing |
| | 9.6 | Diagnostic or test agent produces in vivo fluorescence |
| | 9.7 | Diagnostic or test agent produces visible change in mouth |
| | 9.8 | Diagnostic or test agent produces visible change on skin |
| | 10.1 | IDENTIFICATION OR WARNING FEATURE |
| | 10.2 | Printed or embossed unitary dosage form |
| | 10.3 | Color or color change feature |
| | 10.31 | Combined with animal or insect repellant or insecticide (e.g., shark, fish, roach, etc.) |
| | 10.32 | Combined with ophthalmic or dentifrice preparation |
| | 10.4 | Taste or smell or chemical irritation to the eye, nose, or mouth feature |
| | 40 | COMBUSTIBLE OR CHEMICALLY REACTIVE TO PRODUCE A SMOKE, MIST OR AEROSOL |
| | 400 | PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM |
| | 401 | Cosmetic, antiperspirant, dentifrice |
| | 402 | Wearing apparel, fabric, or cloth |
| | 405 | Biocides; animal or insect repellents or attractants (e.g., disinfectants, pesticides, etc.) |
| | 406 | Ingredients for reducing the noxious effect of the active substances to organisms other than pest (e.g., toxicity reducing compositions, self-destructing compositions, etc.) |
| | 407 | Containing material to enhance the sticking of the active ingredients |
| | 408 | Capsule or pelleted or tablet |
| | 409 | Solid as carrier or diluent |
| | 422 | Implant or insert |
